{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:54:21Z","timestamp":1781632461151,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Zhejiang Provincial Medical and Health Science and Technology Project","award":["2023XY083"],"award-info":[{"award-number":["2023XY083"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Pharm Health Care Sci"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cancer pain remains a prevalent and debilitating symptom among patients with advanced malignancies, significantly compromising quality of life. While clinical guidelines for pain management exist, real-world challenges such as polypharmacy, poor adherence, and drug-related problems (DRPs) hinder effective treatment. Pharmacist-led Medication Therapy Management (MTM) offers a structured approach to address these challenges, but its role in cancer pain management remains underexplored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>This study aimed to evaluate the effect of pharmacist-led MTM on cancer pain management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A pre-post interventional study was conducted using the MTM services implemented in January 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 246 patients were included in the pre-MTM group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009100) and MTM (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009146) groups. Pharmacist-led MTM was associated with better cancer pain score at 30-day follow-up (3.85\u2009\u00b1\u20091.07 VS 4.85\u2009\u00b1\u20091.47,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) and greater reduction in pain scores (1.92\u2009\u00b1\u20090.84 VS 2.81\u2009\u00b1\u20091.21,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) compared to the pre-MTM group. In Additional, the MTM effectively identified and resolved the DRPs, achieving a resolution rate of 73.81%. A lower incidence of adverse drug reactions, including constipation, nausea, and vomiting, was observed in the MTM group (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). Furthermore, pharmacist-led MTM was associated with a higher proportion of patients with high medication adherence, with 67.81% in the MTM group compared with 45% in the pre-MTM group (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). Pharmacist-led MTM was associated with higher patient satisfaction with treatment (4.71\u2009\u00b1\u20091.14 vs. 3.04\u2009\u00b1\u20092.07,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) and follow-up (3.92\u2009\u00b1\u20091.76 vs. 3.46\u2009\u00b1\u20091.70,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.02) compared with the pre-MTM group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Pharmacist-led MTM plays a crucial role in optimizing cancer pain management by reducing DRPs, improving adherence, minimizing adverse drug reactions, and enhancing patient satisfaction. It is an essential component of comprehensive, individualized care that ultimately improves the clinical outcomes and quality of life of patients with cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40780-026-00544-8","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T20:09:48Z","timestamp":1769544588000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The impact of pharmacist-led medication therapy management on the efficacy of cancer pain control: a pre-post interventional study"],"prefix":"10.1186","volume":"12","author":[{"given":"Yu","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunfu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"544_CR1","doi-asserted-by":"crossref","unstructured":"Ragusa C, Pereira B, Balayssac D. Assessment of pain prevalence in cancer patients undergoing anticancer treatments and in cancer survivors after completion of anticancer treatments: A French nationwide cross-sectional study. Int J Cancer 2024.","DOI":"10.1002\/ijc.35280"},{"issue":"11","key":"544_CR2","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1093\/jjco\/hyx124","volume":"47","author":"KM Rau","year":"2017","unstructured":"Rau KM, Chen JS, Wu HB, Lin SF, Huang ML, Tai CJ, Hwang WL, Lu YC, Wang CC, Kuen Hsieh R. Cancer-related pain: a nationwide survey of patients\u2019 treatment modification and satisfaction in Taiwan. Jpn J Clin Oncol. 2017;47(11):1060\u20135.","journal-title":"Jpn J Clin Oncol"},{"issue":"3","key":"544_CR3","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1007\/s11096-020-01150-w","volume":"43","author":"E Schindler","year":"2021","unstructured":"Schindler E, Richling I, Rose O. Pharmaceutical care network Europe (PCNE) drug-related problem classification version 9.00: German translation and validation. Int J Clin Pharm. 2021;43(3):726\u201330.","journal-title":"Int J Clin Pharm"},{"issue":"12","key":"544_CR4","first-page":"828","volume":"32","author":"S Shrestha","year":"2024","unstructured":"Shrestha S, Sapkota S, Teoh SL, Kc B, Paudyal V, Lee SWH, Gan SH. Clinical pharmacist interventions on pain management in cancer patients (PharmaCAP) in low resource settings: a multicenter feasibility-pilot randomized controlled trial. Supportive Care Cancer: Official J Multinational Association Supportive Care Cancer. 2024;32(12):828.","journal-title":"Supportive Care Cancer: Official J Multinational Association Supportive Care Cancer"},{"issue":"1","key":"544_CR5","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.japh.2019.09.005","volume":"60","author":"J Liu","year":"2020","unstructured":"Liu J, Wang C, Chen X, Luo J, Xie J, Li S, Hu J, Shi C. Evaluation of pharmacist interventions as part of a multidisciplinary cancer pain management team in a Chinese academic medical center. J Am Pharmacists Association: JAPhA. 2020;60(1):76\u201380.","journal-title":"J Am Pharmacists Association: JAPhA"},{"issue":"5","key":"544_CR6","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1007\/s11096-021-01247-w","volume":"43","author":"P Zhang","year":"2021","unstructured":"Zhang P, Lv D, Zhao J, Sun S, Li L, Liao Y. Evaluation of pharmacists\u2019 interventions on drug-related problems and drug costs in patients with cancer pain. Int J Clin Pharm. 2021;43(5):1274\u201382.","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"544_CR7","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s40122-021-00342-0","volume":"11","author":"X Zheng","year":"2022","unstructured":"Zheng X, Ding H, Xu S, Xie R, Liu Y, Zhai Q, Fang L, Tong Y, Sun J, Xin W, et al. Pharmacist-Led management improves treatment adherence and quality of life in Opioid-Tolerant patients with cancer pain: A randomized controlled trial. Pain Therapy. 2022;11(1):241\u201352.","journal-title":"Pain Therapy"},{"key":"544_CR8","doi-asserted-by":"publisher","first-page":"117954682412747","DOI":"10.1177\/11795468241274720","volume":"18","author":"B Bulo","year":"2024","unstructured":"Bulo B, Woldu M, Beyene A, Mekonnen D, Engidawork E. The impact of a medication therapy management service on the outcomes of hypertension treatment Follow-Up care in an Ethiopian tertiary hospital: A Pre-Post interventional study. Clin Med Insights Cardiol. 2024;18:11795468241274720.","journal-title":"Clin Med Insights Cardiol"},{"issue":"1","key":"544_CR9","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1186\/s12882-024-03902-6","volume":"25","author":"G Mohammadnezhad","year":"2024","unstructured":"Mohammadnezhad G, Ehdaivand S, Sebty M, Azadmehr B, Ziaie S, Esmaily H. Chronic kidney disease and adherence improvement program by clinical pharmacist-provided medication therapy management; a quasi-experimental assessment of patients\u2019 self-care perception and practice. BMC Nephrol. 2024;25(1):463.","journal-title":"BMC Nephrol"},{"issue":"12","key":"544_CR10","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.sapharm.2025.08.002","volume":"21","author":"S Sirimalla","year":"2025","unstructured":"Sirimalla S, Mateti UV, Shenoy P, Shastry CS, Shetty S. Impact of medication therapy management on medication adherence and health-related quality of life among non-dialysis chronic kidney disease patients. Res Social Administrative Pharmacy: RSAP. 2025;21(12):1090\u20135.","journal-title":"Res Social Administrative Pharmacy: RSAP"},{"issue":"1","key":"544_CR11","doi-asserted-by":"publisher","first-page":"102253","DOI":"10.1016\/j.japh.2024.102253","volume":"65","author":"M Joshi","year":"2025","unstructured":"Joshi M, Pham C, Deng H, Mathew S, Norton RM, Kim K, Touchette DR, Tilton JJ. Cost-effectiveness of a pharmacist-led medication therapy management clinic for management of type 2 diabetes. J Am Pharmacists Association: JAPhA. 2025;65(1):102253.","journal-title":"J Am Pharmacists Association: JAPhA"},{"key":"544_CR12","unstructured":"Fallon M, Giusti R, Aielli F, Hoskin P, Rolke R, Sharma M, Ripamonti CI. Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines. (1569\u20138041 (Electronic))."},{"issue":"5","key":"544_CR13","doi-asserted-by":"publisher","first-page":"e70586","DOI":"10.1002\/cam4.70586","volume":"14","author":"E Belitzky","year":"2025","unstructured":"Belitzky E, Ravani Carvalho LV, Taylor M, Ortiz CN, Baum L, Fiellin DA, Lustberg MB. Psychedelics for cancer pain and associated psychological distress: A narrative review of a potential strategy. Cancer Med. 2025;14(5):e70586.","journal-title":"Cancer Med"},{"issue":"3","key":"544_CR14","doi-asserted-by":"publisher","first-page":"e70018","DOI":"10.1111\/papr.70018","volume":"25","author":"E Henriksen","year":"2025","unstructured":"Henriksen E, Young J, Power C, Chan C. What is cancer pain? Investigating attitudes of patients, carers, and health professionals: A cross-sectional survey. Pain Practice: Official J World Inst Pain. 2025;25(3):e70018.","journal-title":"Pain Practice: Official J World Inst Pain"},{"issue":"1","key":"544_CR15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12913-025-12370-z","volume":"25","author":"Y Liu","year":"2025","unstructured":"Liu Y, Chen T, Li X, Song J, Zhang F. Pharmacists\u2019 knowledge, attitudes, and perceived barriers to cancer pain management: a cross-sectional survey in Chongqing, China. BMC Health Serv Res. 2025;25(1):210.","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"544_CR16","first-page":"163","volume":"33","author":"W Luo","year":"2025","unstructured":"Luo W, Huang H, Zhou Y, Min J, Wang C. Implementation of pharmaceutical strategies using the PDCA cycle for standardized management of cancer pain medications. Supportive Care Cancer: Official J Multinational Association Supportive Care Cancer. 2025;33(3):163.","journal-title":"Supportive Care Cancer: Official J Multinational Association Supportive Care Cancer"},{"key":"544_CR17","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.2147\/JPR.S455852","volume":"17","author":"S Shrestha","year":"2024","unstructured":"Shrestha S, Sapkota S, Paudyal V, Moon Z, Horne R, Gan SH. Translation, cultural adaptation and validation of the medication adherence report scale (MARS-5) in Nepalese cancer patients experiencing pain. J Pain Res. 2024;17:3741\u201353.","journal-title":"J Pain Res"},{"issue":"7","key":"544_CR18","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.jpain.2022.02.002","volume":"23","author":"S Shrestha","year":"2022","unstructured":"Shrestha S, Kc B, Blebil AQ, Teoh SL. Pharmacist involvement in cancer pain management: A systematic review and Meta-Analysis. J Pain. 2022;23(7):1123\u201342.","journal-title":"J Pain"},{"issue":"10","key":"544_CR19","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1248\/bpb.b24-00358","volume":"47","author":"M Yamada","year":"2024","unstructured":"Yamada M, Miyamoto T, Jimaru Y, Torii S, Mitsuba N, Muraki Y, Takahashi K. Impact of interventions by certified pharmacists for outpatients with cancer pain on hospital admission after the introduction of opioid analgesics. Biol Pharm Bull. 2024;47(10):1746\u201350.","journal-title":"Biol Pharm Bull"},{"issue":"6","key":"544_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.sapharm.2024.03.005","volume":"20","author":"S Shrestha","year":"2024","unstructured":"Shrestha S, Iqbal A, Teoh SL, Khanal S, Gan SH, Lee SWH, Paudyal V. Impact of pharmacist-delivered interventions on pain-related outcomes: an umbrella review of systematic reviews and meta-analyses. Res Social Administrative Pharmacy: RSAP. 2024;20(6):34\u201351.","journal-title":"Res Social Administrative Pharmacy: RSAP"},{"key":"544_CR21","doi-asserted-by":"publisher","first-page":"1145323","DOI":"10.3389\/fonc.2023.1145323","volume":"13","author":"A Horinouchi","year":"2023","unstructured":"Horinouchi A, Enokida T, Suzuki S, Kamata H, Kaneko A, Matsuyama C, Fujisawa T, Ueda Y, Ito K, Okano S, et al. A pharmacist-led opioid de-escalation program after completion of chemoradiotherapy in locally advanced head and neck cancer. Front Oncol. 2023;13:1145323.","journal-title":"Front Oncol"},{"issue":"6","key":"544_CR22","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1177\/2374373520921692","volume":"7","author":"C El-Haddad","year":"2020","unstructured":"El-Haddad C, Hegazi I, Hu W. Understanding patient expectations of health care: A qualitative study. J Patient Experience. 2020;7(6):1724\u201331.","journal-title":"J Patient Experience"},{"issue":"1","key":"544_CR23","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1146\/annurev-publhealth-061022-044737","volume":"45","author":"J Richmond","year":"2024","unstructured":"Richmond J, Anderson A, Cunningham-Erves J, Ozawa S, Wilkins CH. Conceptualizing and measuring Trust, Mistrust, and distrust: implications for advancing health equity and Building trustworthiness. Annu Rev Public Health. 2024;45(1):465\u201384.","journal-title":"Annu Rev Public Health"},{"key":"544_CR24","doi-asserted-by":"publisher","first-page":"153473542513707","DOI":"10.1177\/15347354251370781","volume":"24","author":"LF Sara","year":"2025","unstructured":"Sara LF, Ylva W, Marit S, Anna E. The significance of communication and treatment expectations in cancer care: an interview study with cancer care practitioners. Integr Cancer Ther. 2025;24:15347354251370781.","journal-title":"Integr Cancer Ther"},{"key":"544_CR25","volume-title":"Patient satisfaction with healthcare services and the techniques used for its assessment: A systematic literature review and a bibliometric analysis","author":"DC Ferreira","year":"2023","unstructured":"Ferreira DC, Vieira I, Pedro MI, Caldas P, Varela M. Patient satisfaction with healthcare services and the techniques used for its assessment: A systematic literature review and a bibliometric analysis. Volume 11. Basel, Switzerland: Healthcare; 2023. 5."}],"container-title":["Journal of Pharmaceutical Health Care and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40780-026-00544-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40780-026-00544-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40780-026-00544-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:13:46Z","timestamp":1781630026000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40780-026-00544-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["544"],"URL":"https:\/\/doi.org\/10.1186\/s40780-026-00544-8","relation":{},"ISSN":["2055-0294"],"issn-type":[{"value":"2055-0294","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"24 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of People\u2019s Hospital of Kaihua (Approval number: IRB-2022-03).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent to participate in the study was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24"}}